How Expanding GPO Spend Commitments Hurt Healthcare

Group purchasing organizations (GPOs) have played a meaningful role in healthcare supply chains for decades. The original idea was simple: bring hospitals together, leverage collective scale, reduce costs, and simplify purchasing. At their best, GPOs were partners advocating on behalf of health systems.

That’s no longer the reality for many healthcare providers.

Today, health systems are increasingly locked into GPO agreements that require the majority of their spend to flow through a single portfolio. Miss a compliance threshold or spend target, and penalties follow. These contracts don’t just influence purchasing behavior; they dictate it and influence bad behavior.

The result is a model that shifts risk onto the health system, limits supplier choice, and, in some cases, drives decisions that serve GPO economics better than clinical, operational, or patient needs.

There is a better way to think about procurement. And health systems have more leverage than they’re often led to believe.

The Original Premise of GPOs, and What Changed

Originally, GPOs existed to aggregate demand and negotiate favorable pricing, particularly in high-volume, standardized categories like medical-surgical supplies. Products such as exam gloves, syringes, and basic consumables are largely interchangeable, making them ideal for aggregation and national contracting. Participation was largely voluntary. Health systems could opt out when a contract didn’t make clinical, operational, or strategic sense.

Over time, several forces reshaped that model:

• Fewer, larger organizations now control a disproportionate share of healthcare spend.
• GPOs rely heavily on administrative fees paid by suppliers, creating a built-in tension between driving supplier volume and optimizing provider outcomes. In simple terms, lower prices don’t always align with GPO economics.
• As provider margins tightened, GPOs increasingly positioned “compliance” as a substitute for strategy, a way to create savings certainty without addressing fit or performance.
• Once traditional categories like medical supplies and PPI were largely locked in, GPOs pushed aggressively into purchased services. Products like IV solutions are essentially the same from one hospital to the next, making them easy to standardize at scale. Services such as snow removal, HVAC maintenance, or IT staff augmentation are not. They depend on local labor markets, facility complexity, and site-specific service expectations – factors the GPO model was never built to manage effectively.

The result is a landscape defined by mandatory spend commitments, minimum compliance thresholds, and claw-back provisions that penalize health systems for exercising judgment.

How Spend Commitments Trap Health Systems

Modern GPO contracts commonly require health systems to:

• Route 80–90% or more of eligible spend through the GPO.
• Maintain category-level compliance.
• Pay penalties, fees, or rebate claw-backs if targets are missed.
• Extend participation into purchased services and indirect spend, where standardized national contracts often break down.

These provisions are typically framed as “alignment incentives.” In practice, they function more like financial handcuffs. The downstream effects are real and predictable.

GPOs prioritize volume with preferred suppliers, not necessarily the best fit. Health systems are often forced to use vendors that are clinically suboptimal, operationally inconsistent, and poorly suited to specific geographies or care settings. New entrants, regional providers, and differentiated solutions struggle to gain traction because shifting spend threatens compliance. In purchased services, national vendors are favored even when service quality varies widely by location.

Rather than being accountable for contract performance, GPOs shift risk to the health system. Providers pay for “non-compliance” even when decisions are driven by valid clinical or operational needs. Sourcing decisions become about hitting a number, not delivering outcomes.

There’s a long-standing saying in healthcare procurement that the GPO price is just the starting point, even in highly standardized, high-volume med/surg categories. Most leaders understand that GPO pricing is often not truly competitive.

That reality begs an important question: if the GPO price is only a starting point for supplies that are easy to aggregate, how non-competitive is that same starting point when applied to purchased services? In categories driven by local markets, custom scopes, and variable service levels, the idea that a nationally set GPO price represents true market value becomes even harder to justify.

The issue isn’t awareness; it’s constraint. When volume commitments must be protected, the freedom to negotiate aggressively or move to a better-fit supplier largely disappears.

The Impact on Quality and Patient Outcomes

When purchasing decisions are driven by contractual obligation instead of clinical and operational fit, care suffers.

Across health systems, the patterns repeat:

• Clinicians and department leaders are constrained from using preferred suppliers.
• Supply disruptions are tolerated because switching vendors triggers penalties.
• Forced standardization where variation is clinically appropriate.
• “Savings” achieved on paper but offset by labor, utilization, or outcome impacts.
• Purchased services are locked into preferred vendors that limit access to local expertise or flexible service models.

In an environment focused on value-based care, these tradeoffs aren’t just inefficient -- they’re counterproductive.

Why Health Systems Keep Signing These Deals

Despite the risks, many organizations continue to enter aggressive spend-commitment agreements. Common reasons include the appeal of simplicity, short-term financial pressure, and limited internal sourcing capabilities.

Too often, the long-term cost of lost flexibility is underestimated, or there’s no independent expertise available to challenge GPO assumptions during negotiations.

How Health Systems Can, and Should, Push Back

The good news is this: these arrangements are a matter of choice. Health systems have more leverage than they realize, especially when they rethink both the strengths and weaknesses of GPOs.

Minimum spend commitments should never be treated as standard. Health systems should require category-level opt-outs, particularly for purchased services, eliminate penalties tied solely to volume, and tie incentives to performance, not compliance.

Aggregation is not strategy, and it’s not appropriate for every category. Leading organizations use strategic sourcing to evaluate markets, especially in services, and leverage GPOs selectively where the value proposition is clear. Providers should fully understand supplier administrative fee structures, share-back thresholds and tiers, and where GPO incentives may diverge from provider outcomes.

Contracts must explicitly preserve physician-led decision-making, product trials and innovation pilots, and local sourcing where it makes sense. Every agreement should include reasonable termination rights, category-level disengagement options, and protection against retroactive penalties.

Procurement must serve the health system, not the other way around. Working across complex healthcare environments consistently shows that:

• True savings in purchased services come from competition, expertise, and strategy, not aggregation.
• Flexibility produces better outcomes than forced compliance.
• Strategic sourcing outperforms the GPO model, delivering average savings of more than 10% versus GPO pricing in clinical and non-clinical services.

Health systems don’t need to choose between savings and autonomy. With the right approach, they can, and should, have both. Healthcare is too complex, too critical, and too human to be governed by rigid spend quotas and punitive contracts. The future demands procurement models that are smarter, more transparent, and more accountable. Models that empower providers instead of restricting them.